Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

33.45
+0.04000.12%
Pre-market: 32.90-0.5493-1.64%07:16 EDT
Volume:2.54M
Turnover:85.08M
Market Cap:20.57B
PE:26.44
High:33.98
Open:33.36
Low:33.28
Close:33.41
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:0.66
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.45
PE(LYR):21.76

Loading ...

Genmab announces 5.08% stake by Orbis Investment

TIPRANKS
·
May 09

Genmab A/S reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
May 09

Genmab Shares Fall After Net Income Misses Forecast

Dow Jones
·
May 08

Genmab Q1 Net Profit Falls, Revenue Rises

MT Newswires Live
·
May 08

Genmab maintains FY26 guidance

TIPRANKS
·
May 08

Genmab Q1 EPADS $0.083 Misses $0.17 Estimate, Sales $896.000M Beat $890.400M Estimate

Benzinga Earnings
·
May 07

Press Release: Genmab Announces Financial Results for the First Quarter of 2026

Dow Jones
·
May 07

Genmab A/S Stock Rises Wednesday, Underperforms Market

Dow Jones
·
May 07

Genmab A/S expected to post earnings of 18 cents a share - Earnings Preview

Reuters
·
May 05

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
May 05

Earning Preview: Genmab A/S this quarter’s revenue is expected to increase by 17.37%, and institutional views are predominantly bullish

Earnings Agent
·
May 01

Genmab A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
May 01

Genmab Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 30

Genmab price target lowered to $38 from $40 at H.C. Wainwright

TIPRANKS
·
Apr 30

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 30

Genmab: Buy Rating Backed by Expanded Petosemtamab-Keytruda Phase III Trial and Blockbuster Late-Stage Pipeline

TIPRANKS
·
Apr 28

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Apr 28

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Apr 25

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Apr 23